ARCHIVES

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Gori To Leave NCI For Job At Franklin Institute

April 18, 1980

ASCO Picks Charles Balch To Succeed John Durant as Executive Vice President.

January 7, 2000

Peer Review Study Team Plans Hearing

December 12, 1975

Interactive R01 Scores Vary widely, Result Of separate Review

June 11, 1993

NIH Seeks Comment On Reorg Plan For Oncology Study Sections

April 5, 2002

In Brief: Fabien Calvo named chief scientific officer of Cancer Core Europe

December 19, 2014